{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:42:06Z","timestamp":1791996126845,"version":"4.4.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["311862\/2020-9"],"award-info":[{"award-number":["311862\/2020-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ajog.2021.10.004","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T07:48:30Z","timestamp":1633938510000},"page":"633-645.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Perinatal outcomes of first pregnancy after chemotherapy for gestational trophoblastic neoplasia: a systematic review of observational studies and meta-analysis"],"prefix":"10.1016","volume":"226","author":[{"given":"Jose Mauro","family":"Madi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0829-2517","authenticated-orcid":false,"given":"Machline Paim","family":"Paganella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5166-3005","authenticated-orcid":false,"given":"Isnard Elman","family":"Litvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maur\u00edcio","family":"Viggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6356-6413","authenticated-orcid":false,"given":"Eliana Marcia","family":"Wendland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1502-5553","authenticated-orcid":false,"given":"Kevin M.","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil S.","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2942-6182","authenticated-orcid":false,"given":"Antonio","family":"Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross S.","family":"Berkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2021.10.004_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ajog.2010.06.072","article-title":"Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia","volume":"204","author":"Lurain","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl6","key":"10.1016\/j.ajog.2021.10.004_bib2","doi-asserted-by":"crossref","first-page":"vi39","DOI":"10.1093\/annonc\/mdt345","article-title":"Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Seckl","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ajog.2021.10.004_bib3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/ijgc-2018-000028","article-title":"Is there uniformity in definitions and treatment of gestational trophoblastic disease in Europe?","volume":"29","author":"Frijstein","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2021.10.004_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5306\/wjco.v10.i2.28","article-title":"Challenges in the diagnosis and treatment of gestational trophoblastic neoplasia worldwide","volume":"10","author":"Braga","year":"2019","journal-title":"World J Clin Oncol"},{"issue":"Suppl2","key":"10.1016\/j.ajog.2021.10.004_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ijgo.12615","article-title":"Update on the diagnosis and management of gestational trophoblastic disease","volume":"143","author":"Ngan","year":"2018","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ajog.2021.10.004_bib6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ygyno.2015.05.041","article-title":"Fatal gestational trophoblastic neoplasia: an analysis of treatment failures at the Brewer Trophoblastic Disease Center from 1979-2012 compared to 1962-1978","volume":"138","author":"Neubauer","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2021.10.004_bib7","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ygyno.2020.04.704","article-title":"Gestational trophoblastic neoplasia lethality among Brazilian women: a retrospective national cohort study","volume":"158","author":"Freitas","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2021.10.004_bib8","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ygyno.2017.09.007","article-title":"Does hormonal contraception during molar pregnancy follow-up influence the risk and clinical aggressiveness of gestational trophoblastic neoplasia after controlling for risk factors?","volume":"147","author":"Dantas","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2021.10.004_bib9","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/1471-0528.13617","article-title":"Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review","volume":"123","author":"Braga","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2021.10.004_bib10","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1590\/SO100-720320150005366","article-title":"Treatment of low-risk gestational trophoblastic neoplasia comparing biweekly eight-day methotrexate with folinic acid versus bolus-dose actinomycin-D, among Brazilian women","volume":"37","author":"Uberti","year":"2015","journal-title":"Rev Bras Ginecol Obstet"},{"key":"10.1016\/j.ajog.2021.10.004_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jogc.2020.03.001","article-title":"Guideline No. 408: management of gestational trophoblastic diseases","volume":"43","author":"Eiriksson","year":"2021","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2021.10.004_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bpobgyn.2020.10.007","article-title":"Psychological aspects and fertility issues of GTD","volume":"74","author":"Di Mattei","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2021.10.004_bib13","first-page":"228","article-title":"Subsequent pregnancy experience in patients with gestational trophoblastic disease. New England Trophoblastic Disease Center, 1965-1992","volume":"39","author":"Berkowitz","year":"1994","journal-title":"J\u00a0Reprod Med"},{"key":"10.1016\/j.ajog.2021.10.004_bib14","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1471-0528.1987.tb03129.x","article-title":"Fertility after chemotherapy for ovarian germ cell tumours","volume":"94","author":"Pektasides","year":"1987","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2021.10.004_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/00016348809004160","article-title":"Reproductive performance of patients with gestational trophoblastic disease in Hong Kong","volume":"67","author":"Ngan","year":"1988","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2021.10.004_bib16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/gyno.1998.5167","article-title":"Subsequent reproductive experience after treatment for gestational trophoblastic disease","volume":"71","author":"Kim","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2021.10.004_bib17","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.1471-0528.1998.tb10271.x","article-title":"Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome","volume":"105","author":"Woolas","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2021.10.004_bib18","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1525-1438.1999.99018.x","article-title":"Pregnancy outcome after treatment with etoposide (vp-16) for low-risk gestational trophoblastic tumor","volume":"9","author":"Matsui","year":"1999","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2021.10.004_bib19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0090-8258(02)00071-9","article-title":"Risk of abnormal pregnancy completing chemotherapy for gestational trophoblastic tumor","volume":"88","author":"Matsui","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2021.10.004_bib20","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ygyno.2008.10.027","article-title":"Maternal and perinatal outcomes of first pregnancy after chemotherapy for gestational trophoblastic neoplasia in Brazilian women","volume":"112","author":"Braga","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2021.10.004_bib21","series-title":"Cochrane handbook for systematic reviews of interventions version 6.2","article-title":"Chapter 24. Including non-randomized studies on intervention effects","author":"Reeves","year":"2019"},{"key":"10.1016\/j.ajog.2021.10.004_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajog.2021.10.004_bib23","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2021.10.004_bib24","author":"Madi"},{"key":"10.1016\/j.ajog.2021.10.004_bib26","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2021.10.004_bib27","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1126\/science.169.3952.1326","article-title":"Pregnancies after chemotherapy of trophoblastic neoplasms","volume":"169","author":"Van Thiel","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.ajog.2021.10.004_bib28","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/0002-9378(76)90816-4","article-title":"Reproductive performance of women successfully treated for gestational trophoblastic tumors","volume":"125","author":"Walden","year":"1976","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.10.004_bib29","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/1097-0142(197602)37:2+<1043::AID-CNCR2820370809>3.0.CO;2-N","article-title":"Congenital anomalies among children born of mothers receiving chemotherapy for gestational trophoblastic neoplasms","volume":"37","author":"Ross","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2021.10.004_bib30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/bmj.288.6411.103","article-title":"Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours","volume":"288","author":"Rustin","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.ajog.2021.10.004_bib31","first-page":"522","article-title":"Pregnancy after chemotherapy for gestational trophoblastic disease","volume":"35","author":"Ayhan","year":"1990","journal-title":"J\u00a0Reprod Med"},{"issue":"Suppl1","key":"10.1016\/j.ajog.2021.10.004_bib32","first-page":"S65","article-title":"The management of high-risk gestational trophoblastic tumours (GTT)","volume":"60","author":"Newlands","year":"1998","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ajog.2021.10.004_bib33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/gyno.1999.5437","article-title":"Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor","volume":"73","author":"Tuncer","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2021.10.004_bib34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/sj.bjc.6600041","article-title":"The effect of early pregnancy following chemotherapy on disease relapse and foetal outcome in women treated for gestational trophoblastic tumours","volume":"86","author":"Blagden","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajog.2021.10.004_bib35","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1046\/j.1471-0528.2003.02419.x","article-title":"Pregnancy after EMA\/CO for gestational trophoblastic disease: a report from the Netherlands","volume":"110","author":"Lok","year":"2003","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2021.10.004_bib36","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ygyno.2004.02.018","article-title":"Survival rates of patients with choriocarcinoma treated with chemotherapy without hysterectomy: effects of anticancer agents on subsequent births","volume":"93","author":"Goto","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2021.10.004_bib37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejogrb.2006.01.024","article-title":"Clinicopathologic characteristics and subsequent pregnancy outcome in 139 complete hydatidiform moles","volume":"128","author":"Horn","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2021.10.004_bib38","first-page":"333","article-title":"High-risk gestational trophoblastic neoplasia at Gujarat Cancer and Research Institute: thirteen years of experience","volume":"55","author":"Chauhan","year":"2010","journal-title":"J\u00a0Reprod Med"},{"key":"10.1016\/j.ajog.2021.10.004_bib39","first-page":"248","article-title":"Effect of early pregnancy following chemotherapy on disease relapse and fetal outcome in women treated for gestational trophoblastic neoplasia","volume":"59","author":"Williams","year":"2014","journal-title":"J\u00a0Reprod Med"},{"key":"10.1016\/j.ajog.2021.10.004_bib40","first-page":"204","article-title":"Reproductive outcomes after multiagent chemotherapy for high-risk gestational trophoblastic neoplasia","volume":"59","author":"Wong","year":"2014","journal-title":"J\u00a0Reprod Med"},{"key":"10.1016\/j.ajog.2021.10.004_bib41","first-page":"188","article-title":"Subsequent pregnancy outcomes after complete and partial molar pregnancy, recurrent molar pregnancy, and gestational trophoblastic neoplasia: an update from the New England Trophoblastic Disease Center","volume":"59","author":"Vargas","year":"2014","journal-title":"J\u00a0Reprod Med"},{"key":"10.1016\/j.ajog.2021.10.004_bib42","first-page":"205","article-title":"Anti-M\u00fcllerian hormone in patients treated with chemotherapy for gestational trophoblastic neoplasia does not predict short-term fertility","volume":"61","author":"Ghorani","year":"2016","journal-title":"J\u00a0Reprod Med"},{"key":"10.1016\/j.ajog.2021.10.004_bib43","first-page":"3477","article-title":"Prognosis of patients with gestational trophoblastic neoplasia and obstetric outcomes of those conceiving after chemotherapy","volume":"36","author":"Gadducci","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ajog.2021.10.004_bib44","first-page":"373","article-title":"Gestational trophoblastic neoplasia and pregnancy outcome after routine second curettage for hydatidiform mole a retrospective observational study","volume":"61","author":"Kan","year":"2016","journal-title":"J\u00a0Reprod Med"},{"key":"10.1016\/j.ajog.2021.10.004_bib45","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/IGC.0000000000001175","article-title":"Reproductive outcomes after gestational trophoblastic neoplasia. A comparison between single-agent and multiagent chemotherapy: retrospective analysis from the MITO-9 group","volume":"28","author":"Cioffi","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2021.10.004_bib46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40944-018-0243-4","article-title":"Gestational trophoblastic neoplasia\u2014fertility outcomes and survival","volume":"16","author":"Prakash","year":"2018","journal-title":"Indian J Gynecol Oncolog"},{"key":"10.1016\/j.ajog.2021.10.004_bib47","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/bdr2.1589","article-title":"National population-based estimates for major birth defects, 2010-2014","volume":"111","author":"Mai","year":"2019","journal-title":"Birth Defects Res"},{"key":"10.1016\/j.ajog.2021.10.004_bib48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2018.04.003","article-title":"The global epidemiology of preterm birth","volume":"52","author":"Vogel","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2021.10.004_bib49","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1186\/s12884-020-03267-2","article-title":"Rate, determinants, and causes of stillbirth in Jordan: findings from the Jordan Stillbirth and Neonatal Deaths Surveillance (JSANDS) system","volume":"20","author":"Shattnawi","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ajog.2021.10.004_bib50","series-title":"Williams obstetrics","author":"Cunningham","year":"2018"},{"key":"10.1016\/j.ajog.2021.10.004_bib51","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1053\/beog.2000.0123","article-title":"Epidemiology and the medical causes of miscarriage","volume":"14","author":"Regan","year":"2000","journal-title":"Baillieres Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2021.10.004_bib52","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/00016340500494887","article-title":"Spontaneous abortion: a prospective cohort study of younger women from the general population in Denmark. Validation, occurrence and risk determinants","volume":"85","author":"Buss","year":"2006","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2021.10.004_bib53","first-page":"2120","article-title":"Trends in the incidence, rate and treatment of miscarriage-nationwide register-study in Finland, 1998-2016","volume":"34","author":"Linnakaari","year":"2019","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2021.10.004_bib54","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/aogs.13860","article-title":"Pregnancy loss: a 40-year nationwide assessment","volume":"99","author":"Lidegaard","year":"2020","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2021.10.004_bib55","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1136\/ijgc-2019-000604","article-title":"Gestational trophoblastic neoplasia: a meta-analysis evaluating reproductive and obstetrical outcomes after administration of chemotherapy","volume":"29","author":"Tranoulis","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2021.10.004_bib56","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0027-5107(74)90098-0","article-title":"Chromosome aberrations in metaphase II-oocytes. Stage sensitivity in the\u00a0mouse oogenesis to amethopterin and cyclophosphamide","volume":"22","author":"Hansmann","year":"1974","journal-title":"Mutat Res"},{"key":"10.1016\/j.ajog.2021.10.004_bib57","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jncimonographs\/lgi025","article-title":"Appraisal of chemotherapy effects on reproductive outcome according to animal studies and clinical data","volume":"34","author":"Meirow","year":"2005","journal-title":"J\u00a0Natl Cancer Inst Monogr"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937821011030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937821011030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:36:00Z","timestamp":1762079760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937821011030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0002937821011030"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2021.10.004","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perinatal outcomes of first pregnancy after chemotherapy for gestational trophoblastic neoplasia: a systematic review of observational studies and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2021.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}